Glucosamine Price Trend, Index and Forecast

Track the latest insights on glucosamine price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Glucosamine Prices Outlook Q1 2026

• USA: USD 9686/MT
• China: USD 3255/MT
• Germany: USD 8865/MT
• India: USD 6823/MT
• Vietnam: USD 7334/MT

Glucosamine Prices Chart

Get real-time access to monthly/quarterly/yearly prices Request Sample

During the first quarter of 2026, the glucosamine prices in the USA reached 9686 USD/MT in March. Prices moved upward as demand from dietary supplement manufacturers improved after buyers resumed procurement following earlier inventory corrections. Stronger offtake from joint health and mobility supplement brands supported the market, especially as retailers replenished finished goods ahead of seasonal wellness campaigns. During the first quarter of 2026, the glucosamine prices in China reached 3255 USD/MT in March. Prices increased slightly as domestic suppliers balanced moderate demand with stable production activity. The market saw steady interest from nutraceutical manufacturers, although buyers remained cautious due to earlier price weakness. Export inquiries improved gradually as overseas customers returned to restocking, supporting sentiment among producers. During the first quarter of 2026, the glucosamine prices in Germany reached 8865 USD/MT in March. Prices rose as supplement and pharmaceutical buyers increased procurement after a period of cautious inventory control. Demand from joint health formulations remained firm, supported by regular orders from distributors and finished product manufacturers. Import availability from Asian suppliers remained a key pricing factor, with buyers responding to longer shipment planning and quality documentation requirements. During the first quarter of 2026, the glucosamine prices in India reached 6823 USD/MT in March. Prices increased as domestic demand improved from nutraceutical, pharmaceutical, and health supplement manufacturers. Buyers showed stronger interest in regular procurement, supported by stable demand for joint care products and wellness formulations. Importers faced firm offers from overseas suppliers, while local distributors adjusted quotations in line with replacement costs. During the first quarter of 2026, the glucosamine prices in Vietnam reached 7334 USD/MT in March. Prices moved upward as demand from supplement manufacturers and export linked buyers strengthened. The market received support from steady procurement by nutraceutical producers using glucosamine in joint support formulations. Import pricing remained firm, while distributors adjusted offers due to higher replacement cost expectations.

Glucosamine Prices Outlook Q4 2025

• USA: USD 9416/MT
• China: USD 3230/MT
• Germany: USD 8757/MT
• India: USD 6711/MT
• Vietnam: USD 7168/MT

During the fourth quarter of 2025, the glucosamine prices in the USA reached 9416 USD/MT in December. The market experienced a firm upward trend supported by stable demand from the dietary supplement and pharmaceutical sectors. Procurement activities strengthened ahead of the year-end inventory cycle, while steady consumer spending on joint health formulations reinforced buying momentum. Domestic production costs remained elevated due to sustained feedstock expenses and compliance-related operational outlays. During the fourth quarter of 2025, the glucosamine prices in China reached 3230 USD/MT in December. Prices moved upward as export demand improved from North America and Europe, encouraging manufacturers to maintain firm offers. Domestic production conditions were stable, yet feedstock availability remained moderately tight, supporting higher manufacturing costs. Environmental compliance measures and routine plant maintenance in select regions further constrained supply. During the fourth quarter of 2025, the glucosamine prices in Germany reached 8757 USD/MT in December. The market observed a gradual increase driven by stable pharmaceutical demand and replenishment cycles within the health supplement industry. Import dependency on Asian suppliers exposed the market to elevated procurement costs, especially as upstream prices strengthened. Inventory restocking ahead of winter supported consistent purchasing activity. During the fourth quarter of 2025, the glucosamine prices in India reached 6711 USD/MT in December. Prices trended upward due to steady demand from the pharmaceutical and nutraceutical manufacturing sectors. Import costs from key Asian suppliers increased moderately, influencing domestic distributor pricing strategies. Local blending and formulation units maintained healthy production schedules, reinforcing consistent procurement. During the fourth quarter of 2025, the glucosamine prices in Vietnam reached 7168 USD/MT in December. The market reflected upward movement driven by improved export inquiries and firm domestic consumption within the health supplement sector. Manufacturing activity remained stable, though feedstock sourcing costs experienced moderate pressure. Export-oriented producers prioritized long-term contracts, reducing spot availability in the local market.

Glucosamine Prices Outlook Q3 2025

• USA: USD 9253/MT
• China: USD 3126/MT
• Germany: USD 8510/MT
• India: USD 6586/MT
• Vietnam: USD 6974/MT

During the third quarter of 2025, the glucosamine prices in the USA reached 9253 USD/MT in September. The decline in prices this quarter was influenced by stabilized raw material availability, easing pressure on supply chains, and moderate inventory levels among key distributors. Weak domestic demand in the pharmaceutical and nutraceutical segments further contributed to the downward pricing trend. Additionally, fluctuations in transportation costs and competitive pricing from alternative suppliers reinforced the slight reduction, even as production costs remained steady. During the third quarter of 2025, the glucosamine prices in China reached 3126 USD/MT in September. The sharp decline in prices was primarily driven by excess domestic supply and lower export demand. Local manufacturers faced pressure due to increased production capacity, which, coupled with weaker downstream pharmaceutical orders, contributed to price softness. Currency stability and lower logistics costs only partially offset the market downturn. During the third quarter of 2025, the glucosamine prices in Germany reached 8510 USD/MT in September. Prices decreased due to constrained consumer demand and inventory corrections in the wholesale and pharmaceutical sectors. Supply-side adjustments, including improved raw material logistics, resulted in moderate price reductions. Regulatory compliance costs remained stable, but overall cautious purchasing behaviors by healthcare and supplement manufacturers exerted downward pressure. During the third quarter of 2025, the glucosamine prices in India reached 6586 USD/MT in September. The slight upward movement in prices reflected steady demand from the pharmaceutical and nutraceutical sectors and constrained local supply. Suppliers leveraged limited production volumes to maintain margins, while increasing raw material costs contributed to price firmness. Moreover, domestic manufacturers adopted strategic pricing to balance competitive pressures with profitability objectives, which supported the modest increase. During the third quarter of 2025, the glucosamine prices in Vietnam reached 6974 USD/MT in September. Prices reflected moderate demand and consistent production output. While export demand fluctuated, domestic orders provided steady support. Additionally, operational efficiencies in local manufacturing and stable logistics costs prevented significant price volatility. Suppliers maintained cautious pricing strategies to mitigate risks associated with external market uncertainties.

Glucosamine Prices Outlook Q2 2025

• United States: USD 9500/MT
• Germany: USD 9200/MT
• China: USD 3500/MT
• Brazil: USD 4600/MT
• India: USD 6470/MT

During the second quarter of 2025, the glucosamine prices in the United States reached 9500 USD/MT in June. Prices strengthened due to robust demand from nutraceutical manufacturers and increased procurement by pharmaceutical companies. Supply chain constraints, particularly limited availability of high-purity raw materials, contributed to higher pricing. Additionally, logistical cost pressures and seasonal demand surges for joint health supplements supported the upward trend. Market sentiment remained optimistic as buyers secured volumes in anticipation of future price increases. During the second quarter of 2025, the glucosamine prices in Germany reached 9200 USD/MT in June. Prices declined sharply as a result of softened pharmaceutical orders and high stock levels at distribution points. Regulatory scrutiny and cautious purchasing by healthcare manufacturers limited upward price momentum. European market competition further constrained pricing, compelling sellers to adopt more competitive strategies. Despite stable production costs, overall market sentiment favored buyers, leading to notable price corrections. During the second quarter of 2025, the glucosamine prices in China reached 3500 USD/MT in June. The decline in prices was driven by an oversupply of locally produced glucosamine and weaker export demand. Domestic manufacturers faced reduced profit margins, encouraging aggressive pricing adjustments to sustain sales. Improved transportation efficiencies provided limited support but could not offset the downward pressure. Moreover, competitive pricing from regional players contributed to overall market softness. During the second quarter of 2025, the glucosamine prices in Brazil reached 4600 USD/MT in June. The sharp price reduction was due to declining pharmaceutical and nutraceutical consumption, combined with oversupply from local manufacturers. Logistics and import cost reductions provided minimal relief, while sellers implemented discount strategies to move excess stock. Market activity remained sluggish, reflecting cautious procurement behaviors among distributors. During the second quarter of 2025, the glucosamine prices in India reached 6470 USD/MT in June. Prices were fluctuating as local demand continued to support domestic production levels. Slight fluctuations in raw material costs and moderate growth in the pharmaceutical and supplement sectors helped maintain equilibrium. Suppliers maintained consistent pricing policies, balancing inventory levels with market requirements.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing glucosamine prices.

Europe Glucosamine Price Trend

 

Q1 2026:

Glucosamine price index in Europe moved upward as supplement and pharmaceutical demand improved across major consuming markets. Buyers returned to scheduled procurement after earlier stock adjustments, supporting firmer offers from distributors. Import dependence remained a major price driver, as sourcing from Asian producers required longer planning and careful quality documentation. Demand from joint health supplements, mobility support products, and private label wellness formulations stayed firm. Producers and distributors maintained cautious inventory policies, but they avoided deep discounts due to higher replacement cost expectations.

Q4 2025:

In Europe, the glucosamine price index reflected a firm upward trajectory during the fourth quarter. Stable pharmaceutical demand and consistent supplement manufacturing supported procurement activity across major economies. Import dependency on Asian suppliers exposed regional markets to firmer export prices. Energy and operational costs remained steady, sustaining conversion expenses. Balanced inventories and disciplined supplier strategies prevented oversupply conditions.

Q3 2025:

During the third quarter of 2025, the glucosamine price index in Europe reflected moderate softness. Declining demand in pharmaceutical and nutraceutical sectors, coupled with high inventory levels among distributors, led to downward price adjustments. Supply chain efficiencies and stable raw material availability contributed to a controlled reduction in prices. Competitive pressures among European producers reinforced price moderation, while end-user demand remained steady but not sufficient to offset the general market softness.

Q2 2025:

During the second quarter of 2025, the glucosamine price index in Europe showed notable softness. The decline was primarily driven by elevated inventory levels across major distribution hubs, which reduced the urgency for fresh procurement and placed downward pressure on supplier pricing strategies. Pharmaceutical and nutraceutical manufacturers adopted conservative purchasing patterns due to subdued end-user consumption, leading to slower order cycles. Competitive pressures intensified as both regional producers and importers attempted to secure market share in an oversupplied environment, prompting flexible pricing and promotional incentives. This analysis can be extended to include detailed glucosamine price information for a comprehensive list of countries.

Region	Countries Covered
Europe	Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.

North America Glucosamine Price Trend

Q1 2026:

Glucosamine price index in North America increased as demand from nutraceutical brands and contract manufacturers strengthened. Buyers in the United States increased purchases after earlier inventory corrections, supporting firmer market sentiment. Demand from joint care, mobility, and active aging supplement products remained a strong driver. Import pricing influenced the region because many buyers depended on Asian supply sources for raw material availability. Distributors adjusted offers upward as replacement costs rose and lead time concerns encouraged steady procurement. Finished dosage manufacturers preferred regular buying to protect production schedules.

Q4 2025:

In North America, the glucosamine price index demonstrated steady growth throughout the fourth quarter. Strong consumer demand for joint health supplements and pharmaceutical formulations encouraged manufacturers to maintain stable production schedules and forward procurement strategies. Import costs from key Asian suppliers remained elevated, reinforcing higher domestic distributor quotations and limiting discounting flexibility. Contract commitments and year-end restocking cycles further strengthened buying activity across the United States and Canada.

Q3 2025:

In Q3, the glucosamine price index in North America experienced a mild contraction. Supply stabilization and eased logistics costs contributed to a reduction in prices, while cautious purchasing behavior by manufacturers further reinforced softness. Inventory management strategies and competitive pressures among distributors led to moderate downward adjustments. Despite steady domestic demand in healthcare and nutraceutical markets, pricing remained under pressure due to market correction trends.

Q2 2025:

In Q2, the glucosamine price index in North America strengthened due to robust demand and constrained supply conditions. Nutraceutical manufacturers increased their procurement activity, driven by steady consumer interest in joint-health supplements and supportive retail channel performance. Pharmaceutical producers also expanded purchasing volumes, maintaining consistent formulation schedules across therapeutic categories. On the supply side, limited availability of key raw materials and tight manufacturing capacities created upward pressure on pricing, as producers prioritized essential orders. Specific glucosamine historical data within the United States and Canada can also be provided.

Region	Countries Covered
North America	United States and Canada

Middle East and Africa Glucosamine Price Trend

Q1 2026:

According to the price chart for glucosamine, supply chain interruptions, seasonal changes in demand, and geopolitical influences were the main causes of the price fluctuations in the Middle East and Africa.

Q4 2025:

As per the glucosamine price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.

Q3 2025:

The report explores the glucosamine trends and glucosamine price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.  In addition to region-wise data, information on glucosamine prices for countries can also be provided.

Region	Countries Covered
Middle East & Africa	Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.

Asia Pacific Glucosamine Price Trend

Q1 2026:

In Asia Pacific, glucosamine prices increased across several markets as demand improved from supplement manufacturers and export linked buyers. China saw limited upward movement due to adequate supply, but improved export inquiries supported sentiment. India and Vietnam recorded firmer trends as manufacturers increased procurement for capsules, powders, and wellness formulations. Regional buyers remained cautious, yet they continued regular purchases to maintain production schedules. Suppliers held offers stable to firm as downstream demand improved and replacement cost expectations strengthened. Export activity also supported pricing, especially where buyers sought reliable material for nutraceutical applications.

Q4 2025:

In the Asia Pacific, prices trended upward as export demand improved and regional manufacturing operated at stable utilization rates. Producers in major exporting countries prioritized long-term international contracts, which reduced spot market availability and strengthened bargaining power. Feedstock cost firmness and compliance-related operational expenses further supported higher offer levels. Domestic consumption within the pharmaceutical and nutraceutical sectors remained stable, reinforcing baseline demand. Trade flows within Southeast Asia and East Asia remained active, facilitating the continuous movement of goods across borders.

Q3 2025:

During the third quarter of 2025, glucosamine prices in the Asia Pacific were largely shaped by regional supply surpluses and moderate demand from the pharmaceutical and supplement sectors. Competitive dynamics among suppliers encouraged flexible pricing, while operational efficiencies-maintained price stability. The combination of limited external demand and cautious domestic buying contributed to minimal volatility in pricing.

Q2 2025:

During Q2 2025, glucosamine prices in the Asia Pacific were influenced by oversupply conditions and subdued demand growth. Expanded production capacity across key manufacturing hubs, particularly in China and Southeast Asia, contributed to abundant supply, creating downward pressure on market sentiment. Domestic demand within the nutraceutical and pharmaceutical sectors grew only gradually, limiting the absorption of available stocks. Manufacturers responded to the imbalanced supply environment by adopting competitive pricing strategies aimed at sustaining sales volumes and retaining long-standing buyers. This glucosamine price analysis can be expanded to include a comprehensive list of countries within the region.

Region	Countries Covered
Asia Pacific	China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Latin America Glucosamine Price Trend

Q1 2026:

Latin America's abundant natural resources, especially in nations like Chile and Brazil, have a major impact on the glucosamine market. However, glucosamine costs might fluctuate significantly due to political unpredictability and uneven regulatory systems.

Q4 2025:

Latin America's glucosamine market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in glucosamine prices.

Q3 2025:

Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, the glucosamine price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing glucosamine pricing trends in this region.

Q2 2025:

During the second quarter of 2025, glucosamine prices in Latin America experienced a downturn due to weak consumption and oversupply from local producers. Demand from pharmaceutical and nutraceutical manufacturers remained muted as buyers prioritized inventory consolidation and delayed new procurement cycles. The oversupplied market encouraged producers to adopt aggressive pricing strategies, including broad discounting to maintain sales volumes. This comprehensive review can be extended to include specific countries within the region.

Region	Countries Covered
Latin America	Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.

Glucosamine Pricing Report, Market Analysis, and News

IMARC's latest publication, “Glucosamine Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the glucosamine market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of glucosamine at major ports and analyzes the꧒ composition of prices, including FOB and CIF terms. It also presents detailed glucosamine prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting ಞglucosamine pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Glucosamine Industry Analysis

The global glucosamine market size reached USD 991.2 Million in 2025. By 2034, IMARC Group expects the market to reach USD 1,486.1 Million, at a projected CAGR of 4.60% during 2026-2034. The market is primarily driven by the increas𝄹ing demand from pharmaceutical and nutraceutical sectorsꦍ, growing awareness of joint health, and rising prevalence of osteoarthritis.

Latest News and Developments:

• June 2025: A systematic review examined the safety and efficacy of glucosamine and chondroitin in humans. Conducted by researchers from Cedarville University, the analysis reviewed 146 studies, most of which focused on osteoarthritis and joint pain. The majority of trials reported positive outcomes, with minimal safety concerns. Commonly evaluated together, glucosamine and chondroitin were typically administered at daily doses of 1500 mg and 1200 mg. Overall findings suggested both supplements are effective and well-tolerated, though further research was recommended.

Product Description

Glucosamine is an amino sugar commonly used in dietary supplements and pharmaceutical formulations for joint health support. It is usually available as glucosamine sulfate, glucosamine hydrochloride, or N acetyl glucosamine. The product is commonly derived from chitin obtained from shellfish sources, though fermentation based alternatives are also used. Glucosamine is valued for its role in cartilage support, connective tissue maintenance, and mobility focused formulations. It is generally supplied as a crystalline powder with good stability under controlled storage conditions. Industrial applications are mainly found in nutraceuticals, tablets, capsules, sachets, functional powders, and healthcare products. It is also used in veterinary supplements and specialty formulations for bone and joint care.

Report Coverage

Key Attributes	Details
Product Name	Glucosamine
Report Features	Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Glucosamine Price Analysis, and Segment-Wise Assessment.
Currency/Units	US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered	The current coverage includes analysis at the global and regional levels only.    Based on your requirements, we can also customize the report and provide specific information for the following countries:    Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand   Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece   North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers	Company Overview Business Description Recent Trends and Developments
Customization Scope	The report can be customized as per the requirements of the customer
Report Price and Purchase Option	Plan A: Monthly Updates - Annual Subscription Scope Historical Data for the Current Month Forecast for Next Month Total Deliverables Per Year: 12 (One Per Month) Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year Plan B: Quarterly Updates - Annual Subscription Scope Historical Data for the Current Quarter Forecast for Next Quarter Total Deliverables Per Year: 4 (One Per Quarter) Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year Plan C: Biannually Updates - Annual Subscription Scope Historical Data for the Current Half Forecast for the Next Half Total Deliverables Per Year: 2 (One Per 6 Months) Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support	360-degree analyst support after report delivery
Delivery Format	PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of glucosamine price index, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting glucosamine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The glucosamine price chart ensures our clients remain at the forefront of the industry.